Authors:
SETTE H
PESSOA MG
BARROS MA
CURY RA
MARUJO W
TERRAULT NA
Citation: H. Sette et al., ASSESSING THE CONTRIBUTION OF TREATMENT DURATION TO RATE OF RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS-C (HCV) INFECTION RECEIVING COMBINED INTERFERON (IFN) AND RIBAVIRIN (RBV), Hepatology, 28(4), 1998, pp. 1650-1650
Authors:
BARROS M
SETTE H
MARUJO W
CURY R
OSAWA C
PEREIRA D
VIANNA R
Citation: M. Barros et al., ACUTE URIC-ACID NEPHROPATHY ASSOCIATED TO RIBAVIRIN USE WHEN COMBINEDWITH CYCLOSPORINE AFTER LIVER-TRANSPLANTATION, Hepatology, 26(4), 1997, pp. 1400-1400
Citation: W. Marujo et al., SEVERE ANEMIA INDUCED BY RIBAVIRIN USE WHEN COMBINED WITH CYCLOSPORINE IN LIVER-TRANSPLANT PATIENTS, Hepatology, 26(4), 1997, pp. 1717-1717
Authors:
ZERBINI MC
ALMEIDA W
WAKAMATSU A
MARUJO W
LOPES LHAC
MAKSOUD JG
Citation: Mc. Zerbini et al., DNA CONTENT AND PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN PERSISTENT NEONATAL HYPERINSULINEMIC HYPOGLYCEMIA (PNHH), Laboratory investigation, 70(1), 1994, pp. 10000149-10000149